What's breaking now, across thousands of outlets.
Estuary Biotherapeutics raised the curtain on Friday with $103 million to support the advancement of two preclinical gene therapy candidates for the most common type of inherited kidney disease. The company’s cash comes from a ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Thomas Kahlert has been off HIV treatment since 2018 after a stem-cell transplant from a donor who was not HIV-resistant. Why it matters, and why it isn’t a cure for most people with HIV.
Imagine a teenager in a vulnerable mental health crisis being admitted to a ward full of adults. Thankfully, regional officials […]
Nashik: The Food and Drug Administration (FDA) has launched a crackdown on food safety violations in Nashik, seizing 151 kg of allegedly substandard cakes and cupcakes from Ajmeri Bakery in the…
